The Malaysian Reserve

Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Pre…

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has ...
The Week

New era of health: How GLP-1 drugs are revolutionising obesity and diabetes treatment

Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...
Le Lézard

Vanda Pharmaceuticals Announces FDA Approval of NEREUStm (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of ...

Vanda Pharmaceuticals Inc. (Vanda) today announced that the U.S. Food and Drug Administration (FDA) has approved NEREUStm (tradipitant), an oral neurokinin-1 (NK-1) receptor antagonist, for the ...

Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Announces FDA Approval of NEREUS (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Healio

AmblyoPlay improves visual acuity, hand-eye coordination in amblyopia

Children with amblyopia who used the AmblyoPlay app 5 days a week for 6 months had significant improvements in visual acuity, ...
Ophthalmology Times

Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)

Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...